SOLZY Trademark

Trademark Overview


On Tuesday, August 19, 2025, a trademark application was filed for SOLZY with the United States Patent and Trademark Office. The USPTO has given the SOLZY trademark a serial number of 99345441. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, August 19, 2025. This trademark is owned by Harmony Biosciences Management, Inc.. The SOLZY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and therapeutic agents for treating genetic, neurological, neurodevelopmental, developmental, and central nervous system disorders and diseases having neurological and neurobehavioral symptoms or manifestations; medicated skin care preparations, namely, creams and lotions; medicated skin care preparations, namely, creams and lotions for treating genetic, neurological, neurodevelopmental, developmental, and central nervous system disorders and diseases having neurological and neurobehavioral symptoms or manifestations; transdermal patches featuring pharmaceutical preparations and therapeutic agents for treating genetic, neurological, neurodevelopmental, developmental, and central nervous system disorders and diseases having neurological and neurobehavioral symptoms or manifestations; pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and ...
solzy

General Information


Serial Number99345441
Word MarkSOLZY
Filing DateTuesday, August 19, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, August 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations and therapeutic agents for treating genetic, neurological, neurodevelopmental, developmental, and central nervous system disorders and diseases having neurological and neurobehavioral symptoms or manifestations; medicated skin care preparations, namely, creams and lotions; medicated skin care preparations, namely, creams and lotions for treating genetic, neurological, neurodevelopmental, developmental, and central nervous system disorders and diseases having neurological and neurobehavioral symptoms or manifestations; transdermal patches featuring pharmaceutical preparations and therapeutic agents for treating genetic, neurological, neurodevelopmental, developmental, and central nervous system disorders and diseases having neurological and neurobehavioral symptoms or manifestations; pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech disorders and diseases, traumatic brain injury, and viral diseases and disorders; Pharmaceutical preparations for the treatment of fragile x syndrome, substance related addiction, autism and autism spectrum disorders, epilepsy, seizure diseases and disorders, anxiety, aphasias, stuttering, post-traumatic stress disorder

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 19, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHarmony Biosciences Management, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPlymouth Meeting, PA 19462

Trademark Events


Event DateEvent Description
Tuesday, August 19, 2025NEW APPLICATION ENTERED
Tuesday, August 19, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 19, 2025APPLICATION FILING RECEIPT MAILED